The results suggested that molecular imaging of apoptosis might accurately predict trastuzumab-induced regression of both MMTV/HER2 transgenic mouse mammary tumors and BT474 xenografts, as witnessed by the higher accumulation of NIR700-Annexin V in the tumor xenografts [19]. Here, ERBB2 is linked to neoplasm.